A new model of care for familial hypercholesterolaemia from Western Australia: Closing a major gap in preventive cardiology

Heart Lung and Circulation

Volumn 19, Issue 7, 2010, Pages 419-422

  Watts, Gerald F ^a,b   van Bockxmeer, Frank M ^a,c   Bates, Timothy ^a,b   Burnett, John R ^a,b,c   Juniper, Amanda ^a,d   O'Leary, Peter ^d,e,f  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f CURTIN UNIVERSITY   (Australia)

Author keywords

Cascade screening; Familial hypercholesterolaemia; Genetic testing; Model of care; Preventive cardiology; Results; Treatment

Indexed keywords

FLUINDOSTATIN; PRAVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

APHERESIS; ARTICLE; AUSTRALIA; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY COUNSELING; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; ADOLESCENT; ADULT; ALGORITHM; CARDIOVASCULAR DISEASES; CHILD; CLINICAL PATHWAY; FEMALE; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PATIENT SELECTION; PREVENTIVE HEALTH SERVICE; RISK REDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; CARDIOVASCULAR DISEASES; CHILD; CRITICAL PATHWAYS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT SELECTION; PREVENTIVE HEALTH SERVICES; RISK REDUCTION BEHAVIOR; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 77953808299     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2010.02.002     Document Type: Article

References (6)

1. Watts G.F., Lewis B., Sullivan D.R. Familial hypercholesterolaemia: a missed opportunity in preventive medicine. Nat Clin Pract Cardiovasc Med 2007, 4:404-405.
2. Model of Care: Familial Hypercholesterolaemia. http://www.genomics.health.wa.gov.au/fh/index.cfm.
3. Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolaemia. Atherosclerosis 2004, 173:55-68. International Panel on Management of Familial Hypercholesterolaemia.
4. Sullivan D. Guidelines for the diagnosis and management of familial hypercholesterolaemia. Heart Lung Circ 2006, 16:25-27. Members of the CSANZ Cardiovascular Genetics Working Group.
5. Wierzbicki A.S., Humphries S.E., Minhas R., on behalf of the Guidelines Development Group Familial hypercholesterolaemia: summary of NICE guidance. BMJ 2008, 337:509-510.
6. Marks D., Thorogood M., Neil H.A.W., Wonderling D., Humphries S.E. Comparing costs and benefits over a 10 year period for strategies for familial hypercholesterolaemia screening. J Public Health Med 2003, 25:47-52.